Trademark: 97106239
Status Date
Tuesday, April 4, 2023
Registration Number
7020508
Registration Date
Tuesday, April 4, 2023
Filing Date
Wednesday, November 3, 2021
Published for Opposition
Tuesday, September 20, 2022
5 Drug for human use, namely, pharmaceutical preparation for the treatment of neuroinflammatory disease administered subcutaneously or intravenously to patients with amyotrophic lateral sclerosis
The wording "TVALA" has no meaning in a foreign language.
Apr 4, 2023
Notice Of Registration Confirmation Emailed
Apr 4, 2023
Registered-Principal Register
Feb 28, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 25, 2023
Allowed Principal Register - Sou Accepted
Feb 24, 2023
Statement Of Use Processing Complete
Feb 1, 2023
Use Amendment Filed
Feb 23, 2023
Case Assigned To Intent To Use Paralegal
Feb 1, 2023
Teas Statement Of Use Received
Nov 15, 2022
Noa E-Mailed - Sou Required From Applicant
Sep 20, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 20, 2022
Published For Opposition
Aug 31, 2022
Teas Change Of Correspondence Received
Aug 31, 2022
Notification Of Notice Of Publication E-Mailed
Aug 13, 2022
Approved For Pub - Principal Register
Aug 13, 2022
Examiner's Amendment Entered
Aug 13, 2022
Notification Of Examiners Amendment E-Mailed
Aug 13, 2022
Examiners Amendment E-Mailed
Aug 13, 2022
Examiners Amendment -Written
Aug 12, 2022
Assigned To Examiner
Nov 13, 2021
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
